Clinical Trial: Definition of Novel Optoacoustic Biomarkers of Psoriasis and Psoriatic Arthritis

U.S., Oct. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07885345) titled 'Definition of Novel Optoacoustic Biomarkers of Psoriasis and Psoriatic Arthritis' on Sept. 30.

Brief Summary: This study investigates changes in the skin and joints of people with psoriasis (PsO) and psoriatic arthritis (PsA) using two non-invasive imaging methods called raster-scan optoacoustic mesoscopy (RSOM) and multispectral optoacoustic tomography (MSOT).

The study will include 192 adults, including people with PsO, people with PsA, people at increased risk of developing these conditions, and healthy participants. RSOM will be used to examine small blood vessels and other features of the skin, while MSOT will be used to exami...